[go: up one dir, main page]

AU2001266264A1 - System and methods for optimized drug delivery and progression of diseased and normal cells - Google Patents

System and methods for optimized drug delivery and progression of diseased and normal cells

Info

Publication number
AU2001266264A1
AU2001266264A1 AU2001266264A AU6626401A AU2001266264A1 AU 2001266264 A1 AU2001266264 A1 AU 2001266264A1 AU 2001266264 A AU2001266264 A AU 2001266264A AU 6626401 A AU6626401 A AU 6626401A AU 2001266264 A1 AU2001266264 A1 AU 2001266264A1
Authority
AU
Australia
Prior art keywords
diseased
progression
methods
drug delivery
normal cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266264A
Inventor
Zvia Agur
Sarel Fleishmann
Kirill Skomorovski
Moshe Vardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Optimata Ltd
Original Assignee
Optimata Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optimata Ltd filed Critical Optimata Ltd
Publication of AU2001266264A1 publication Critical patent/AU2001266264A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Databases & Information Systems (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AU2001266264A 2000-10-19 2001-06-15 System and methods for optimized drug delivery and progression of diseased and normal cells Abandoned AU2001266264A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09691053 2000-10-19
US09/691,053 US6871171B1 (en) 2000-10-19 2000-10-19 System and methods for optimized drug delivery and progression of diseased and normal cells
PCT/IB2001/001178 WO2002032458A2 (en) 2000-10-19 2001-06-15 System and methods for optimized drug delivery and progression of diseased and normal cells

Publications (1)

Publication Number Publication Date
AU2001266264A1 true AU2001266264A1 (en) 2002-04-29

Family

ID=24774975

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266264A Abandoned AU2001266264A1 (en) 2000-10-19 2001-06-15 System and methods for optimized drug delivery and progression of diseased and normal cells

Country Status (5)

Country Link
US (6) US6871171B1 (en)
EP (2) EP1326641A1 (en)
AU (1) AU2001266264A1 (en)
IL (2) IL155272A0 (en)
WO (1) WO2002032458A2 (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932945A1 (en) * 1999-07-14 2001-01-25 Siemens Ag Process, arrangement and computer program for preprocessing
US20050154536A1 (en) * 2001-08-30 2005-07-14 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Two-part drug discovery system
CA2458667A1 (en) * 2001-08-30 2003-03-13 The University Of Pittsburgh Of The Commonwealth System Of Higher Educat Ion Of Pennsylvania Method for predicting the outcome of an infection
US6904434B1 (en) * 2001-12-18 2005-06-07 Siebel Systems, Inc. Method and system for providing real-time clinical trial enrollment data
US7286970B2 (en) * 2002-01-07 2007-10-23 The Regents Of The University Of California Computational model, method, and system for kinetically-tailoring multi-drug chemotherapy for individuals
AU2003213771A1 (en) * 2002-03-06 2003-09-22 Tomotherapy Incorporated Method for modification of radiotherapy treatment delivery
EP1546985A4 (en) * 2002-09-20 2010-10-27 Neurotech Res Pty Ltd Condition analysis
US9342657B2 (en) * 2003-03-24 2016-05-17 Nien-Chih Wei Methods for predicting an individual's clinical treatment outcome from sampling a group of patient's biological profiles
US20050095628A1 (en) * 2003-09-12 2005-05-05 Krempin David W. Program for regulating health conditions
CA2540280A1 (en) * 2003-10-07 2005-04-21 Entelos, Inc. Simulating patient-specific outcomes
EP1844416A2 (en) * 2005-02-04 2007-10-17 Entelos, Inc. Method for defining virtual patient populations
US7957507B2 (en) 2005-02-28 2011-06-07 Cadman Patrick F Method and apparatus for modulating a radiation beam
US8175808B2 (en) * 2005-04-01 2012-05-08 Sloan Kettering Institute For Cancer Research Method for determining disease treatment duration
US8232535B2 (en) 2005-05-10 2012-07-31 Tomotherapy Incorporated System and method of treating a patient with radiation therapy
WO2007034331A2 (en) * 2005-06-13 2007-03-29 Optimata, Ltd. System recommending an optimal treatment protocol
WO2007014106A2 (en) 2005-07-22 2007-02-01 Tomotherapy Incorporated System and method of delivering radiation therapy to a moving region of interest
CN101268474A (en) * 2005-07-22 2008-09-17 断层放疗公司 Method and system for estimating delivered dose
US7639854B2 (en) * 2005-07-22 2009-12-29 Tomotherapy Incorporated Method and system for processing data relating to a radiation therapy treatment plan
WO2007014027A2 (en) * 2005-07-22 2007-02-01 Tomotherapy Incorporated System and method of remotely analyzing operation of a radiation therapy system
WO2007014104A2 (en) * 2005-07-22 2007-02-01 Tomotherapy Incorporated System and method of evaluating dose delivered by a radiation therapy system
WO2007014092A2 (en) * 2005-07-22 2007-02-01 Tomotherapy Incorporated Method of placing constraints on a deformation map and system for implementing same
JP2009502255A (en) * 2005-07-22 2009-01-29 トモセラピー・インコーポレーテッド Method and system for assessing quality assurance criteria in the delivery of treatment plans
WO2007014105A2 (en) * 2005-07-22 2007-02-01 Tomotherapy Incorporated Method and system for adapting a radiation therapy treatment plan based on a biological model
US7609809B2 (en) 2005-07-22 2009-10-27 Tomo Therapy Incorporated System and method of generating contour structures using a dose volume histogram
US8442287B2 (en) 2005-07-22 2013-05-14 Tomotherapy Incorporated Method and system for evaluating quality assurance criteria in delivery of a treatment plan
KR20080039919A (en) * 2005-07-22 2008-05-07 토모테라피 인코포레이티드 Systems and methods for detecting respiratory status in patients undergoing radiation therapy
WO2007014094A2 (en) * 2005-07-22 2007-02-01 Tomotherapy Incorporated Method of and system for predicting dose delivery
CA2616293A1 (en) * 2005-07-23 2007-02-01 Tomotherapy Incorporated Radiation therapy imaging and delivery utilizing coordinated motion of gantry and couch
US7734423B2 (en) * 2005-09-23 2010-06-08 Crowley Davis Research, Inc. Method, system, and apparatus for virtual modeling of biological tissue with adaptive emergent functionality
WO2007094830A1 (en) * 2005-11-10 2007-08-23 In Silico Biosciences, Inc. Method and apparatus for computer modeling the human brain for predicting drug effects
US20100121618A1 (en) * 2006-03-10 2010-05-13 Neurotech Research Pty Limited Subject modelling
CN101536006A (en) * 2006-11-10 2009-09-16 皇家飞利浦电子股份有限公司 An apparatus, method, computer-readable medium, and use for therapy planning in treatment of a patient
US8571803B2 (en) * 2006-11-15 2013-10-29 Gene Network Sciences, Inc. Systems and methods for modeling and analyzing networks
WO2008100624A2 (en) * 2007-02-16 2008-08-21 Merrimack Pharmaceuticals, Inc. Antibodies against erbb3 and uses thereof
US20090062624A1 (en) * 2007-04-26 2009-03-05 Thomas Neville Methods and systems of delivering a probability of a medical condition
US8494871B2 (en) * 2007-07-13 2013-07-23 Koninklijke Philips N.V. Decision support system for acute dynamic diseases
CN101796521A (en) 2007-09-04 2010-08-04 皇家飞利浦电子股份有限公司 Multi-treatment planning apparatus and method
US20090070087A1 (en) * 2007-09-07 2009-03-12 Newman Richard D Virtual tissue with emergent behavior and modeling method for producing the tissue
WO2009091590A1 (en) * 2008-01-16 2009-07-23 Immuneering Corporation Method and system for assessing immune system response
GB2464032A (en) * 2008-05-15 2010-04-07 Soar Biodynamics Ltd Methods and systems for integrated health systems
US8112290B2 (en) * 2008-05-16 2012-02-07 Adolor Corporation Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug
WO2009156194A1 (en) * 2008-06-23 2009-12-30 Simula Innovation As Computation of drug composition
CN102224255A (en) * 2008-08-15 2011-10-19 梅里麦克制药股份有限公司 Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response
CA2744886C (en) * 2008-10-20 2018-11-13 Epitome Pharmaceuticals Limited Methods and systems for improved pharmaceutical intervention in coagulation control
US20110286960A1 (en) * 2008-11-02 2011-11-24 Optimata Ltd. Cancer therapy by docetaxel and granulocyte colony-stimulating factor (g-csf)
WO2010075446A1 (en) * 2008-12-23 2010-07-01 Soar Biodynamics, Ltd. Methods and systems for prostate health monitoring
EP2859893A1 (en) 2010-03-11 2015-04-15 Merrimack Pharmaceuticals, Inc. Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers
JP2012061053A (en) * 2010-09-14 2012-03-29 Yuuki Kitaoka Administration apparatus, method of operating the same, and administration method
EP2754076B1 (en) * 2011-09-08 2021-03-10 Fresenius Medical Care Holdings, Inc. System and method of modeling erythropoiesis and its management
US9679111B2 (en) 2012-11-05 2017-06-13 Fresenius Medical Care Holdings, Inc. System and method of modeling erythropoiesis including iron homeostasis
WO2014072950A1 (en) * 2012-11-09 2014-05-15 Cellworks Research India Private Limited System and method for development of therapeutic solutions
EP2962309B1 (en) 2013-02-26 2022-02-16 Accuray, Inc. Electromagnetically actuated multi-leaf collimator
CN106133521A (en) * 2013-10-02 2016-11-16 苏瑞科技有限公司 For treating the specific immunotherapy of the sufferer of heterogeneous tumor
WO2015100459A2 (en) 2013-12-27 2015-07-02 Merrimack Pharmaceuticals, Inc. Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies
WO2015118529A1 (en) 2014-02-04 2015-08-13 Optimata Ltd. Method and system for prediction of medical treatment effect
WO2015143446A1 (en) * 2014-03-21 2015-09-24 The Regents Of The University Of California Nanomedicine optimization with feedback system control
US20150310574A1 (en) * 2014-04-25 2015-10-29 Christopher A. Williams Protocol builder for managing patient care
CA2953385C (en) 2014-06-30 2024-07-02 Evolving Machine Intelligence Pty Ltd A system and method for modelling system behaviour
WO2016100875A2 (en) * 2014-12-18 2016-06-23 Fresenius Medical Care Holdings, Inc. System and method of conducting in silico clinical trials
US10184006B2 (en) 2015-06-04 2019-01-22 Merrimack Pharmaceuticals, Inc. Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors
KR102170297B1 (en) * 2019-12-16 2020-10-26 주식회사 루닛 Method and system for providing interpretation information on pathomics data

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5930154A (en) * 1995-01-17 1999-07-27 Intertech Ventures, Ltd. Computer-based system and methods for information storage, modeling and simulation of complex systems organized in discrete compartments in time and space
US5657255C1 (en) * 1995-04-14 2002-06-11 Interleukin Genetics Inc Hierarchic biological modelling system and method
US5879673A (en) * 1996-01-25 1999-03-09 Genentech, Inc. Administration of thrombopoietin on a single day only
US5860917A (en) * 1997-01-15 1999-01-19 Chiron Corporation Method and apparatus for predicting therapeutic outcomes
CA2326579C (en) * 1998-04-03 2011-01-18 Triangle Pharmaceuticals, Inc. Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens

Also Published As

Publication number Publication date
US20030097220A1 (en) 2003-05-22
US7133814B2 (en) 2006-11-07
US20020095258A1 (en) 2002-07-18
US8504303B2 (en) 2013-08-06
WO2002032458A2 (en) 2002-04-25
US8055491B2 (en) 2011-11-08
US20070213961A1 (en) 2007-09-13
US6871171B1 (en) 2005-03-22
US7266483B2 (en) 2007-09-04
US20120284005A1 (en) 2012-11-08
IL155272A (en) 2013-01-31
EP1326641A1 (en) 2003-07-16
IL155272A0 (en) 2003-11-23
EP2329850A3 (en) 2012-11-21
US20060167637A1 (en) 2006-07-27
EP2329850A2 (en) 2011-06-08

Similar Documents

Publication Publication Date Title
AU2001266264A1 (en) System and methods for optimized drug delivery and progression of diseased and normal cells
AU2001233526A1 (en) Stent delivery system and method of use
AU2001281344A1 (en) Angulated stent delivery system and method of use
AU6271401A (en) Drug administering system and administering method
AU2001286940A1 (en) Drug delivering prostheses and methods of use
AU2002332580A1 (en) Cell storage and delivery system
AU5141500A (en) Self-expanding stent delivery system and method of use
AU2002362744A1 (en) Prostatic stent and delivery system
AU4904601A (en) Stent and stent delivery assembly and method of use
AU1719800A (en) Drug delivery systems and methods
AU5060499A (en) Hydrodynamically balanced oral drug delivery system
AU4248600A (en) Combined imaging and pdt delivery system
AU5343899A (en) Catheter drug delivery system and method for use
AU2001270300A1 (en) Drug delivery formulations and targeting
AU9676198A (en) Drug delivery and gene therapy delivery system
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
AU2002252152A1 (en) Tissue electroperforation for enhanced drug delivery and sampling
AU1100201A (en) Methods of in vivo gene transfer using a sleeping beauty transposon system
AU3287699A (en) Ultrasound-mediated drug delivery
AU2001266910A1 (en) Secure medical test and result delivery system
AU2003210497A1 (en) Gene delivery system and methods of use
AU2938100A (en) Transdermal drug delivery system and method
AU3520900A (en) Implantable drug delivery system
AU2637100A (en) Delivery system and methods for gene therapy
AU2002237711A1 (en) System and method for the delivery of information